Ifp Advisors, Inc Horizon Therapeutics Public LTD CO Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 09, 2024	SELL	$0.0 - $116.3 $0 - $81,410	-700 Reduced 67.83%	332 $0
Q1 2023 Apr 18, 2023	SELL	$107.32 - $113.5 $99,378 - $105,101	-926 Reduced 47.29%	1,032 $112,000
Q4 2022 Feb 07, 2023	SELL	$62.39 - $113.8 $30,446 - $55,534	-488 Reduced 19.95%	1,958 $78,000
Q3 2022 Nov 08, 2022	BUY	$58.92 - $84.67 $14,081 - $20,236	239 Added 10.83%	2,446 $101,000
Q2 2022 Sep 06, 2022	BUY	$79.4 - $116.36 $175,235 - $256,806	2,207 New	2,207 $96,000
Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $175,235 - $256,806	-2,207 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$86.42 - $109.81 $49,777 - $63,250	576 Added 35.32%	2,207 $232,000
Q1 2022 Aug 08, 2022	BUY	$86.42 - $109.81 $48,222 - $61,273	558 Added 52.0%	1,631 $171,000
Q4 2021 Jan 12, 2022	BUY	$98.56 - $119.91 $985 - $1,199	10 Added 0.94%	1,073 $116,000
Q3 2021 Oct 06, 2021	BUY	$91.91 - $110.37 $275 - $331	3 Added 0.28%	1,063 $118,000
Q2 2021 Jul 13, 2021	SELL	$86.24 - $95.92 $1,811 - $2,014	-21 Reduced 1.94%	1,060 $99,000
Q1 2021 Apr 30, 2021	SELL	$71.83 - $95.48 $3.26 Million - $4.33 Million	-45,341 Reduced 97.67%	1,081 $99,000
Q4 2020 Jan 25, 2021	SELL	$67.0 - $84.39 $31,490 - $39,663	-470 Reduced 1.0%	46,422 $3.4 Million
Q3 2020 Oct 29, 2020	BUY	$55.23 - $79.93 $111,951 - $162,018	2,027 Added 4.52%	46,892 $3.64 Million
Q2 2020 Aug 05, 2020	BUY	$30.2 - $56.98 $1.31 Million - $2.48 Million	43,503 Added 3194.05%	44,865 $2.48 Million
Q1 2020 May 12, 2020	BUY	$24.87 - $38.56 $6,864 - $10,642	276 Added 25.41%	1,362 $40,000
Q4 2019 Jan 17, 2020	BUY	$25.43 - $36.67 $17,114 - $24,678	673 Added 162.95%	1,086 $40,000
Q3 2019 Nov 07, 2019	BUY	$23.0 - $27.97 $9,499 - $11,551	413 New	413 $11,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account